University of Illinois at Chicago
Announcement of an Exempt Purchase
Vendor: CuraScript, Lake Mary, FL
Amount: An estimated $900,000
An estimated start date of 8/30/2017 through 4/30/2022
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Friday, December 15, 2017
The University awarded a contract for Ocaliva.
Ocaliva is a drug used to treat liver disease (primary biliary cholangitis).
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Ocaliva is only available from CuraScript and there is only a small supply of it to treat five candidate patients at UIC.
For additional information, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.